Angiogenesis in the uterine cervix.

Our objective was to present current data pertaining to angiogenesis of the uterine cervix. We conducted a computerized search to identify relevant studies published in the English language literature. MEDLINE, Current Contents and Index Medicus were searched utilizing the terms: angiogenesis, uterine cervix, intraepithelial neoplasia, squamous cell carcinoma, and adenocarcinoma, from 1966 through June 1999. In contrast to the cyclic phases of the menstrual cycle of the ovary and endometrium in which angiogenesis plays a significant physiologic role, angiogenesis in the uterine cervix is involved primarily in neoplastic processes. These include intraepithelial disease, human papilloma-related disease, and microinvasive and invasive squamous cell and adenocarcinoma of the cervix. In invasive squamous cell and adenocarcinoma of the uterine cervix, angiogenesis appears to be a prognostic indicator for overall survival and disease-free survival. Initial trial studies with anti-angiogenic (angio-inhibitor) therapy such as TNP-470 have been reported and concurrent antitumor activity observed in a limited number of patients with advanced (inoperable or metastatic) disease.

[1]  P. Hui,et al.  Invasive squamous cell carcinoma and cervical intraepithelial neoplasia III of uterine cervix. Morphologic differences other than stromal invasion. , 1994, American journal of clinical pathology.

[2]  C. Verschraegen,et al.  A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[4]  J. Kodama,et al.  Placenta growth factor is abundantly expressed in human cervical squamous cell carcinoma. , 1997, European journal of gynaecological oncology.

[5]  S. Dobbs,et al.  Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia. , 1997, British Journal of Cancer.

[6]  M. Nair,et al.  Increased angiogenesis in the uterine cervix associated with human papillomavirus infection. , 1999, Pathology, research and practice.

[7]  M. Klagsbrun,et al.  Regulators of angiogenesis. , 1991, Annual review of physiology.

[8]  M. Mitze,et al.  Tumor vascularity--a novel prognostic factor in advanced cervical carcinoma. , 1995, Gynecologic oncology.

[9]  D. Hanahan,et al.  Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice. , 1997, Cancer research.

[10]  B. Davidson,et al.  Angiogenesis in Uterine Cervical Intraepithelial Neoplasia and Squamous Cell Carcinoma: An Immunohistochemical Study , 1997, International Journal of Gynecological Pathology.

[11]  J. Folkman.  What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[12]  N. Kinukawa,et al.  Angiogenesis in adenocarcinoma of the uterine cervix , 1998, Cancer.

[13]  R. Jaffe,et al.  Angiogenesis in the human female reproductive tract. , 1995, Obstetrical & gynecological survey.

[14]  Anthony J. Guidi,et al.  Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. , 1995, Journal of the National Cancer Institute.

[15]  W Kuhn,et al.  3D Color Power Angio™ imaging: a new method to assess intracervical vascularization in benign and pathological conditions , 1998, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[16]  Rutgers Jl,et al.  Angiogenesis in uterine cervical squamous cell carcinoma , 1995 .

[17]  J. Richie,et al.  Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. , 1993, Journal of the National Cancer Institute.

[18]  T. Tamaya,et al.  Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine cervical cancers , 1999, British Journal of Cancer.

[19]  A. Kaider,et al.  Tumor angiogenesis in stage IB cervical cancer: correlation of microvessel density with survival. , 1998, American journal of obstetrics and gynecology.

[20]  D L Wiggins,et al.  Tumor angiogenesis as a prognostic factor in cervical carcinoma. , 1995, Gynecologic oncology.

[21]  Urban Deutsch,et al.  Angiopoietin-1 induces sprouting angiogenesis in vitro , 1998, Current Biology.

[22]  A. Van Daele,et al.  Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer. , 1998, British Journal of Cancer.

[23]  A. Kaider,et al.  Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasia. , 1997, Journal of the National Cancer Institute.

[24]  K. Smith-McCune,et al.  Demonstration and characterization of the angiogenic properties of cervical dysplasia. , 1994, Cancer research.

[25]  M C Weissler,et al.  Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. , 1998, Cancer research.

[26]  M. Klagsbrun,et al.  Vascular endothelial growth factor and its receptors. , 1996, Cytokine & growth factor reviews.

[27]  A Reinthaller,et al.  Prognostic value of tumour microvessel density in cancer of the uterine cervix stage IB to IIB. , 1995, Anticancer research.

[28]  D. Sherer,et al.  Angiogenesis in Squamous Cell Carcinoma In Situ and Microinvasive Carcinoma of the Uterine Cervix , 1996, Obstetrics and gynecology.

[29]  R. Mattingly,et al.  Angiogenesis of cervical neoplasia. , 1975, American journal of obstetrics and gynecology.

[30]  J. Folkman,et al.  How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. , 1986, Cancer research.

[31]  William T. Creaseman.  Modifications in the staging for Stage I vulvar and Stage I cervical cancer , 1995, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[32]  G Brix,et al.  Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival. , 1998, Cancer research.

[33]  J. Folkman,et al.  Angiostatin induces and sustains dormancy of human primary tumors in mice , 1996, Nature Medicine.

[34]  B. Davidson,et al.  Macrophage infiltration and angiogenesis in cervical squamous cell carcinomaclinicopathologic correlation , 1999, Acta obstetricia et gynecologica Scandinavica.

[35]  G Brix,et al.  Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. , 1997, Cancer research.